Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122167) titled 'Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions' on Aug. 7.

Study Type: Observational

Primary Sponsor: MDCECRO LLC

Condition: Cardiovascular Stenosis Artery

Intervention: Device: Peripheral Drug-eluting Stent System

Recruitment Status: Recruiting

Date of First Enrollment: June 2, 2025

Target Sample Size: 153

Countries of Recruitment: Poland

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122167

Published by HT Digital Content Services with permission from Health Daily Digest....